More than a third of patients in the SOT/HSCT and TNF-i cohort had a BMI ≥30; while a normal BMI (18.5–24.9) was observed in 35.8% of patients in the PID/SID cohort. The gene discussed is TNF; the disease is pelvic inflammatory disease.